ATLASBionano Genomics (BNGO) earnings date: Nov 10, 2026
Bionano Genomics (BNGO) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 10, 2026, after the close. Analysts expect EPS of -$0.56.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on BNGO
| Last price | $1.16 (+0.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.1% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Bionano Genomics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Bionano Genomics reports on Nov 10, 2026. One email the day before, with ATLAS’s read on Bionano Genomics. You can switch it off at any time.
Alert me before BNGO reportsFree to start. Creating an account takes under a minute.
Notify me when Bionano Genomics reports
Track BNGO free Add Bionano Genomics to a free ATLAS watchlist and see its next report date in one place.
BNGO earnings at a glance
| Next report (confirmed) | Tue, Nov 10, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.56 |
| Last report | Aug 10, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +7.0% |
| Average move around a report | ±3.0% (last 5) |
| Sector | Healthcare · Medical Instruments & Supplies |
Bionano Genomics earnings history: last 5 reports
Bionano Genomics last reported on Aug 10, 2026: EPS of -$0.60 against an estimate of -$0.67 (+10.5% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 10, 2026 | -$0.67 | -$0.60 | +10.5% | Beat | +2.6% |
| Jun 17, 2026 | $3.12 | $3.16 | +1.3% | In line | -0.9% |
| May 13, 2026 | -$0.95 | -$0.75 | +21.1% | Beat | -5.6% |
| Apr 27, 2026 | -$0.30 | -$0.25 | +16.7% | Beat | -1.7% |
| Apr 9, 2026 | -$0.07 | -$0.08 | -14.3% | Miss | -4.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for BNGO
See the fair value, the probability range and the earnings history of Bionano Genomics on its ATLAS page.
Bionano Genomics (BNGO) stock analysisPlans from €3.99 a month.
Bionano Genomics earnings: frequently asked questions
When does Bionano Genomics (BNGO) report earnings?
Bionano Genomics is scheduled to report on Tuesday, November 10, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for BNGO?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.56 per share (USD). Estimates can change before the report.
How often does BNGO beat earnings estimates?
Of its last 5 reports with a recorded result, Bionano Genomics beat the EPS estimate 3 times; the average surprise was +7.0%. Past results do not predict the next one.
How much does BNGO move around earnings?
Over its last 5 reports the stock moved an average of 3.0% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Bionano Genomics beat earnings estimates last quarter?
Bionano Genomics last reported on Aug 10, 2026: EPS of -$0.60 against an estimate of -$0.67 (+10.5% surprise), a beat.
How much does BNGO usually move in a day?
On a normal trading day the ATLAS model puts BNGO’s one-day range at about ±4.1%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 10, 2026
Educational information, not investment advice. Disclaimer